Cite
HARVARD Citation
Hu, X. et al. (n.d.). RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity. Journal for immunotherapy of cancer. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hu, X. et al. (n.d.). RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity. Journal for immunotherapy of cancer. p. . [Online].